Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Ensuring Compliance with FDA Quality System Regulations (21 CFR 820)

Posted on By

SOP for Ensuring Compliance with FDA Quality System Regulations (21 CFR 820)

Comprehensive Guide to Ensuring Compliance with FDA Quality System Regulations (21 CFR 820)

1) Purpose

The purpose of this SOP is to define a structured approach for achieving and maintaining compliance with the FDA’s Quality System Regulation (QSR) outlined in 21 CFR Part 820. This ensures that all processes involved in the design, production, and distribution of medical devices meet regulatory requirements for quality and safety.

2) Scope

This SOP applies to all departments and processes involved in the lifecycle of medical devices, including design, manufacturing, quality assurance, and distribution. It is relevant to all personnel responsible for implementing and maintaining the Quality Management System (QMS) as per FDA requirements.

3) Responsibilities

– Quality Assurance (QA): Ensures compliance with QSR requirements, oversees audits, and reviews documentation.
– Regulatory Affairs: Monitors regulatory updates, ensures alignment with FDA requirements, and prepares for inspections.
– Department Managers: Implement QSR-compliant processes within their teams and maintain accurate records.
– Training Coordinators: Provide training to employees on QSR compliance and related procedures.
– Internal Auditors: Conduct audits to ensure ongoing compliance with QSR standards.

4) Procedure

4.1 Establishing a Quality Management System (QMS)
4.1.1 Quality Manual
– Develop a Quality Manual that

defines the scope of the QMS, key processes, and regulatory references, including 21 CFR 820.
– Include procedures for document control, record keeping, and regulatory compliance.

4.1.2 Quality Policy and Objectives
– Establish a quality policy demonstrating the organization’s commitment to product quality, safety, and compliance with regulatory requirements.
– Define measurable quality objectives aligned with QSR requirements.

See also  SOP for Maintaining Production Area Cleanliness

4.1.3 Organizational Structure
– Define the organizational structure, roles, and responsibilities related to QMS activities.
– Assign a Management Representative to oversee compliance with QSR and liaise with the FDA.

4.2 Design and Development Controls
4.2.1 Design Planning
– Develop a Design and Development Plan outlining design inputs, outputs, and review stages.
– Ensure the plan includes risk management activities as per ISO 14971.

4.2.2 Design Documentation
– Maintain a Design History File (DHF) containing:
– Design and development plans.
– Design inputs and outputs.
– Verification and validation records.
– Design review minutes and approvals.

4.2.3 Design Transfer
– Document and validate the transfer of design to manufacturing to ensure reproducibility and compliance.

4.3 Document and Data Control
4.3.1 Document Management
– Implement a document control system to ensure that:
– Only approved versions of documents are accessible.
– Obsolete documents are removed or archived to prevent misuse.
– All changes are documented with version history and approvals.

4.3.2 Record Retention
– Retain records for the duration specified by FDA regulations or as defined in internal policies.
– Maintain a secure electronic or physical storage system to ensure records are accessible during FDA inspections.

4.4 Production and Process Controls
4.4.1 Process Validation
– Validate all production processes that affect product quality, including sterilization, packaging, and assembly.
– Maintain records of validation activities in Process Validation Reports.

See also  SOP for Conducting Root Cause Analysis in Quality Control

4.4.2 Work Instructions and Specifications
– Provide clear and accessible work instructions, including process parameters and inspection criteria.
– Ensure operators are trained on these instructions.

4.4.3 Monitoring and Control
– Implement controls to monitor production processes, including environmental conditions and equipment calibration.
– Document any deviations and corrective actions taken.

4.5 Corrective and Preventive Actions (CAPA)
4.5.1 Non-Conformance Reporting
– Establish a system for identifying, documenting, and addressing non-conformities.
– Use Non-Conformance Reports (NCRs) to document deviations and initiate corrective actions.

4.5.2 Root Cause Analysis
– Conduct root cause analysis for non-conformities using tools such as the 5 Whys or Fishbone Diagram.
– Document findings and actions taken in the CAPA report.

4.5.3 Preventive Actions
– Implement preventive actions based on trends and audit findings.
– Record preventive measures and monitor their effectiveness.

4.6 Device Master Record (DMR)
4.6.1 Contents of the DMR
– Include the following in the DMR:
– Device specifications
– Production and process specifications
– Quality assurance procedures
– Packaging and labeling specifications

4.6.2 Maintenance
– Update the DMR whenever changes are made to processes, specifications, or materials.
– Ensure DMRs are accessible for FDA inspections.

4.7 Internal Audits and Management Reviews
4.7.1 Internal Audits
– Develop an annual audit schedule to assess compliance with 21 CFR 820.
– Use audit findings to identify gaps and improve processes.

4.7.2 Management Reviews
– Conduct management reviews at least annually to evaluate the effectiveness of the QMS.
– Include inputs such as audit results, CAPA effectiveness, and quality objectives.

See also  SOP for Conducting Internal Quality Audits

4.8 Preparing for FDA Inspections
4.8.1 Inspection Readiness
– Maintain inspection-ready documentation, including training records, CAPA logs, and device master records.
– Conduct mock inspections to identify and address potential gaps.

4.8.2 Responding to FDA Observations
– Address FDA observations promptly with documented corrective actions.
– Submit a response to the FDA detailing actions taken to resolve issues.

5) Abbreviations

– QSR: Quality System Regulation
– QA: Quality Assurance
– CAPA: Corrective and Preventive Actions
– DHF: Design History File
– DMR: Device Master Record
– FDA: Food and Drug Administration
– NCR: Non-Conformance Report
– SOP: Standard Operating Procedure

6) Documents

– Quality Manual
– Design History File (DHF)
– Device Master Record (DMR)
– Non-Conformance Reports (NCR)
– CAPA Logs
– Process Validation Reports

7) Reference

– FDA CFR Title 21, Part 820: Quality System Regulation
– ISO 13485: Medical devices – Quality management systems
– ISO 14971: Application of Risk Management to Medical Devices

8) SOP Version

– Version: 1.0
– Effective Date: DD/MM/YYYY
– Approved by: [Name/Title]

Annexure

Annexure 1: Internal Audit Checklist Template

Section Requirement Compliance Status Remarks
Document Control Are documents controlled and up-to-date? Compliant All documents reviewed

Annexure 2: CAPA Log Template

CAPA ID Description Root Cause Corrective Action Status Completion Date
CAPA-001 Deviation in sterilization process Equipment malfunction Equipment repair and recalibration Completed DD/MM/YYYY
Medical Devices Tags:FDA Medical device SOP requirements, GMP SOP for medical devices, ISO 13485 SOP for Medical device, Medical device compliance SOP, Medical device packaging SOP template, Medical device post-market surveillance SOP, Medical device quality control SOP, Medical device quality SOP, Medical device regulatory SOP, Medical device SOP, SOP for change control in medical device, SOP for device design control, SOP for equipment calibration in medical devices, SOP for handling complaints in medical devices, SOP for manufacturing medical devices, SOP for medical device audits, SOP for medical device inspection, SOP for medical device labeling, SOP for medical device manufacturing, SOP for medical device packaging inspection, SOP for Medical device raw material, SOP for medical device testing, SOP for non-conforming products in medical devices, SOP for packaging medical devices, SOP for product validation, SOP for production planning in medical devices, SOP for risk management in medical devices, SOP for sterilization packaging validation, SOP for sterilization process of Medical device, SOP for traceability in medical device manufacturing

Post navigation

Previous Post: Aerosol: SOP for Operational Qualification (OQ) of Filling Machines – V 2.0
Next Post: API Manufacturing: SOP for In-Process Sampling Technique – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version